Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Olaratumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Olaratumab Antibody Licensed from Lilly Demonstrates Proof of Concept
    Olaratumab Antibody Licensed from Lilly Demonstrates Proof of Concept

    17 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/olaratumab-antibody-licensed-from-lilly-demonstrates-proof-of-concept-as-a-theranostic-radiopharmaceutical-301798405.html

    PR NEWSWIRE
    17 Apr 2023
    Share Share
    Lilly inks licensing deal for cancer therapy with Australian biotech Telix
    Lilly inks licensing deal for cancer therapy with Australian biotech Telix

    12 Apr 2022

    // D. Lokuwithania SEEKING ALPHA

    https://seekingalpha.com/news/3822270-eli-lilly-in-pact-with-australian-biotech-telix-for-cancer-therapy

    D. Lokuwithania SEEKING ALPHA
    12 Apr 2022
    Share Share
    Lilly inks licensing deal for cancer therapy with Australian biotech Telix
    Lilly inks licensing deal for cancer therapy with Australian biotech Telix

    11 Apr 2022

    // Dulan Lokuwithania SEEKING ALPHA

    https://seekingalpha.com/news/3822270-eli-lilly-in-pact-with-australian-biotech-telix-for-cancer-therapy

    Dulan Lokuwithania SEEKING ALPHA
    11 Apr 2022
    Share Share
    Keytruda is First to Add Indications Under TGA’s Provisional Approval Pathway
    Keytruda is First to Add Indications Under TGA’s Provisional Approval Pathway

    18 Jul 2019

    // Zachary Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/7/mercks-keytruda-is-first-to-add-indications-under

    Zachary Brennan RAPS
    18 Jul 2019
    Share Share
    Lilly Bio-Medicines chief Christi Shaw steps aside, leaving key launches behind
    Lilly Bio-Medicines chief Christi Shaw steps aside, leaving key launches behind

    11 Jul 2019

    // Eric Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/pharma/amid-important-launches-lilly-s-bio-medicines-head-shaw-steps-aside

    Eric Sagonowsky FIERCE PHARMA
    11 Jul 2019
    Share Share
    Suffering a series of setbacks, Eli Lilly’s oncology executes 2 of its top drugs
    Suffering a series of setbacks, Eli Lilly’s oncology executes 2 of its top drugs

    30 Apr 2019

    // John Carroll ENDPTS

    https://endpts.com/suffering-a-series-of-setbacks-eli-lillys-oncology-group-quietly-executes-2-of-its-top-mid-stage-drugs/

    John Carroll ENDPTS
    30 Apr 2019
    Share Share